Current prostate cancer screening and treatment strategies may not support a holistic nationwide program

Abstract

The diversity of the United Kingdom population and its health care personnel makes it unique for research into evidence-based prostate cancer screening and management strategies.• Therefore, ensuring that appropriate systems and services are available to enhance treatment support for men with underlying risk factors should be a priority for health care providers.• More efforts are also needed to ensure the representation of men of Black ethnic origin and underserved populations in future prostate cancer research used to inform clinical guidelines.

Prostate‐specific antigen screening: A kind of Russian roulette regardless of race or risk

“…The USPSTF states the following: "There is inadequate evidence to assess whether the benefits for African American men and men with a family history aged 55 to 69 years are different than the benefits for the average-risk population." 2 Nnate and Ball 1 have not presented such data either. Furthermore, because prostate cancer occurs in the elderly and the effects of death from other causes are significant, the end point should be OS; CSM is not appropriate.…”